What is the recommended propranolol (beta-blocker) dosing for a patient experiencing palpitations after taking the first dose of Vyvanse (lisdexamfetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Palpitations After First Dose of Vyvanse: Propranolol Dosing

For a patient experiencing palpitations after taking the first dose of Vyvanse (lisdexamfetamine), propranolol should be administered at 0.5-1 mg intravenously over 1 minute, which can be repeated up to a total dose of 0.1 mg/kg if required. 1

Immediate Management

When a patient presents with palpitations after taking Vyvanse, follow this approach:

  1. Initial assessment: Determine if the patient is stable or unstable

    • If unstable (hypotension, altered mental status): Immediate intervention required
    • If stable with symptomatic palpitations: Proceed with medication management
  2. First-line propranolol dosing:

    • IV administration: 0.5-1 mg over 1 minute 1
    • Can be repeated every 5 minutes as needed
    • Maximum total dose: 0.1 mg/kg (typically not exceeding 5-10 mg in most adults)
  3. Oral propranolol alternative:

    • For less severe symptoms: 10-20 mg orally
    • Can be titrated up to 40-160 mg in divided or single dose with long-acting formulations 1
    • Maximum daily dose: 160 mg when using standard formulation

Monitoring and Precautions

  • Vital sign monitoring: Check blood pressure and heart rate before each dose and 5-10 minutes after administration

  • Contraindications: Avoid in patients with:

    • Asthma or obstructive airway disease
    • Decompensated heart failure
    • AV block greater than first degree
    • Severe bradycardia 1
  • Warning signs to monitor:

    • Hypotension
    • Bradycardia
    • Bronchospasm
    • Worsening heart failure symptoms

Ongoing Management

For patients requiring continued management of stimulant-induced palpitations:

  • Maintenance dosing:

    • 30-60 mg daily in divided doses or single dose with long-acting formulations
    • Adjust based on symptom control and tolerability 1
  • Alternative options if propranolol is contraindicated:

    • Metoprolol: 5 mg IV over 1-2 minutes, repeated as required every 5 minutes to maximum 15 mg 1
    • Atenolol: 5 mg IV over 5 minutes, repeat 5 mg in 10 minutes if symptoms persist 1

Special Considerations

  • Stimulant interaction: Beta-blockers effectively counteract the peripheral sympathetic effects of stimulants like Vyvanse
  • Duration of therapy: Consider short-term use until patient adapts to Vyvanse or Vyvanse dosing is adjusted
  • Timing: For preventive use, administer propranolol 30-60 minutes before Vyvanse

Common Pitfalls

  • Overtreatment: Excessive beta-blocker dosing can cause significant bradycardia or hypotension
  • Undertreatment: Inadequate dosing may fail to control symptoms
  • Abrupt discontinuation: Never stop beta-blockers abruptly as this can lead to rebound tachycardia
  • Overlooking anxiety: Some patients may have anxiety-induced palpitations exacerbated by stimulants, which may respond well to propranolol 2

By following this protocol, you can effectively manage palpitations in patients starting Vyvanse therapy while minimizing adverse effects from both medications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Exacerbation of panic disorder during propranolol therapy.

Journal of clinical psychopharmacology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.